Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization

Hsiao Wen Wang, Ping Lun Jiang, Shen Fu Lin, Hung Jun Lin, Keng Liang Ou, Win Ping Deng, Lin Wen Lee, Yi You Huang, Pi Hui Liang, Der Zen Liu

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)


The mucosal immune system produces secretory IgA (sIgA) as the first line of defense against invasion by foreign pathogens. Our aim was to develop a galactose-modified liposome as a targeted carrier which can be specifically recognized by macrophage, one of the most important antigen presenting cells. First, galactose was covalently conjugated with 1,2-didodecanoyl-sn-glycero-3- phosphoethanolamine (DLPE) to give a targeted ligand, a galactosyl lipid. The galactosyl lipid was then incorporated into a liposomal bilayer to form a galactosylated liposome carrier. Further, the ovalbumin (OVA) was encapsulated into the galactosylated liposome carriers and mice were intranasally immunized. Confocal laser scanning microscopy and flow cytometry analysis showed that the targeted galactosylated liposome carrier had a higher uptake rate than unmodified liposomes. The targeted galactosylated liposome induced higher levels of tumor necrosis factor-α and interleukin-6 production than unmodified liposomes (P < 0.05). Furthermore, 6-week-old BALB/c female mice immunized with the OVA-encapsulated targeted galactosylated liposome had significantly higher OVA-specific s-IgA levels in the nasal and lung wash fluid (P < 0.05). In addition, the targeted galactosylated liposome simultaneously augmented the serum IgG antibody response. In summary, the OVA-encapsulated targeted galactosylated liposome induced significantly higher mucosal IgA and systemic IgG antibody titers and is a potential antigen delivery carrier for further clinical applications.

Original languageEnglish
Pages (from-to)5681-5688
Number of pages8
JournalActa Biomaterialia
Issue number3
Publication statusPublished - Mar 2013


  • Galactose
  • Mucosal immunity
  • Targeted liposomes
  • s-IgA

ASJC Scopus subject areas

  • Biotechnology
  • Biomaterials
  • Biochemistry
  • Biomedical Engineering
  • Molecular Biology


Dive into the research topics of 'Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization'. Together they form a unique fingerprint.

Cite this